These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 413718)

  • 1. Effect of the combination of Corynebacterium parvum and levamisole on murine tumors.
    Anaclerio A; Conti G; Moras ML; Barale C; Spreafico F
    Eur J Cancer (1965); 1977 Dec; 13(12):1451-53. PubMed ID: 413718
    [No Abstract]   [Full Text] [Related]  

  • 2. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K; Rella W; Goldin A
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
    [No Abstract]   [Full Text] [Related]  

  • 4. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 5. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in cancer patients given Corynebacterium parvum/levamisole immunotherapy.
    Gatenby PA; Basten A; Tattersall MH; Fox RM
    Lancet; 1980 May; 1(8177):1082. PubMed ID: 6103412
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of immunological and anti-tumour effects of orally administered Corynebacterium papvum in mice.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Mar; 31(3):359-63. PubMed ID: 1156520
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined use of local irradiation and Corynebacterium parvum in the treatment of the murine line 1 lung carcinoma.
    Ullrich RL; Adams LM
    Radiat Res; 1978 Feb; 73(2):267-73. PubMed ID: 204955
    [No Abstract]   [Full Text] [Related]  

  • 10. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM; Ullrich RL
    Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemo-immunotherapy with adriamycin in experimental tumor systems.
    Tagliabue A; Polentarutti N; Vecchi A; Mantovani A; Spreafico F
    Eur J Cancer (1965); 1977 Jul; 13(7):657-65. PubMed ID: 598392
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Corynebacterium parvum on tumour metastases in mice.
    Castro JE
    Br J Surg; 1977 Oct; 64(10):721-4. PubMed ID: 922293
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of Corynebacterium parvum in dogs and a study of its distribution following intravenous injection.
    Owen LN; Lewis JC; Morgan DR; Gorman NT
    Eur J Cancer (1965); 1980 Aug; 16(8):999-1005. PubMed ID: 6777166
    [No Abstract]   [Full Text] [Related]  

  • 14. The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.
    Boeryd B; Benktson A
    Clin Exp Metastasis; 1983; 1(3):289-95. PubMed ID: 6546203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of preoperative C. parvum vaccine to modify secondary disease following excision of two non-immunogenic murine carcinomas.
    Hewitt HB; Blake ER
    Br J Cancer; 1978 Aug; 38(2):219-23. PubMed ID: 698036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the antitumor action of Corynebacterium parvum by stress.
    Turney TH; Harmsen AG; Jarpe MA
    Physiol Behav; 1986; 37(4):555-8. PubMed ID: 3092254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer patients treated with Corynebacterium parvum. Phase I toxicity study.
    Yadeau R; Bates HA; Fortuny I
    Minn Med; 1979 Sep; 62(9):673-5. PubMed ID: 503003
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of nonspecific immunotherapy on the course of murine melanoma.
    Woods JE; Ritts RE
    J Surg Oncol; 1977; 9(1):15-20. PubMed ID: 839793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabelling of Corynebacterium parvum and its distribution in mice.
    Sadler TE; Cramp WA; Castro JE
    Br J Cancer; 1977 Mar; 35(3):357-68. PubMed ID: 851511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.